Establishment Labs Holdings (ESTA) Total Non-Current Liabilities (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Total Non-Current Liabilities of $334.2 million for Q1 2026, up 13.97% year-over-year from $293.2 million in Q1 2025, and up 0.5% quarter-over-quarter from $332.5 million in Q4 2025.
Establishment Labs Holdings (ESTA) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $334.2 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 13.97% year-over-year to $334.2 million; the TTM figure through Mar 2026 stood at $334.2 million (up 13.97% YoY), while the FY2025 annual figure was $332.5 million, up 13.84% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $334.2 million, up from $332.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $334.2 million in Q1 2026, with the low at $91.9 million in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $243.4 million (2024), against an average of $248.7 million.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities surged 151.88% in 2022, then gained 4.25% in 2024.
- Establishment Labs Holdings' Total Non-Current Liabilities stood at $217.6 million in 2022, then gained by 14.24% to $248.6 million in 2023, then rose by 17.48% to $292.1 million in 2024, then rose by 13.84% to $332.5 million in 2025, then increased by 0.5% to $334.2 million in 2026.
- Business Quant data shows ESTA's Total Non-Current Liabilities at $334.2 million in Q1 2026, $332.5 million in Q4 2025, and $321.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | 328.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 328.23 Mn |
| Mar 31, 2026 | 334.15 Mn |
| Dec 31, 2025 | 332.48 Mn |
| Sep 30, 2025 | 321.42 Mn |
| Jun 30, 2025 | 305.24 Mn |
| Mar 31, 2025 | 293.18 Mn |
| Dec 31, 2024 | 292.06 Mn |
| Sep 30, 2024 | 248.68 Mn |
| Jun 30, 2024 | 238.61 Mn |
| Mar 31, 2024 | 243.38 Mn |
| Dec 31, 2023 | 248.60 Mn |
| Sep 30, 2023 | 238.54 Mn |
| Jun 30, 2023 | 228.43 Mn |
| Mar 31, 2023 | 223.53 Mn |
| Dec 31, 2022 | 217.62 Mn |
| Sep 30, 2022 | 186.13 Mn |
| Jun 30, 2022 | 184.02 Mn |
| Mar 31, 2022 | 91.90 Mn |
| Dec 31, 2021 | 86.40 Mn |
| Sep 30, 2021 | 84.65 Mn |